AxoGen to receive $28.55 mln from Oberland

Oberland has agreed to provide $28.55 million in financing to AxoGen. According to AxoGen, the capital will be used to pay down its debt and retire the company's royalty agreement with PDL BioPharma. AxoGen is a medical tech firm focused on peripheral nerve repair.

DealsNorth AmericaUSBriefs